Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001415889-25-017666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-18 | 2025-06-16 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.1K | +295% | $0 |
| D | 2025-06-18 | 2025-06-16 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $64.77 | -10.5K | 14.6K | -42% | -$680.1K |
| D | 2025-06-18 | 2025-06-16 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -18.8K | 131.2K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-16 | M | A | 18,750 | $0.00 | 25,098 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2025-06-16 | S | D | 10,501 | $64.77 | 14,597 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-06-16 | M | D | 18,750 | $0.00 | 131,250 | D | — · — to — | 18,750 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |